Patent Application
20230053441
The present invention relates to a DNA detection method and a DNA detection system, and particularly relates to digital PCR.
Conventional genetic test includes techniques such as PCR (PTLs 2 to 4) and real-time PCR (NPL 1). In these techniques, there is a problem that measurement reproducibility is deteriorated when the amount of a gene to be detected (herein referred to as a “target gene or target DNA”) is small.
As a technique for solving this problem, digital PCR (PTL 1) has been developed. Using digital PCR, it is possible to quantify a trace amount of DNA by determining whether DNA is 0 (absent) or 1 (present) using a limitedly diluted sample and detecting the DNA.
An example of a detection method of digital PCR is shown below. First, a DNA polymerase, a primer and a fluorescent-labeled probe necessary for PCR are added to the limitedly diluted specimen to prepare a PCR reaction solution. The PCR reaction solution is divided into micropartitions such as wells or droplets. At this time, one molecule of the target gene or target DNA is contained or not contained in each partition.
Next, the target gene or target DNA in the micropartition is amplified by PCR. The target gene or target DNA can be quantified by measuring a fluorescence intensity of each micropartition after PCR and counting the number of micropartitions having a fluorescence intensity exceeding threshold.
In such digital PCR, since a limitedly diluted specimen is used, it is possible to suppress the influence of a component derived from the specimen, which is a factor that inhibits reaction of PCR. In addition, since a calibration curve is not required, the absolute amount of target DNA can be directly measured.
By the way, in conventional PCR, it is known that reaction efficiency decreases due to the presence of a reaction inhibitor in a reaction solution, formation of a secondary structure of a template DNA, insufficient design of a primer, and the like.
On the other hand, in digital PCR, since the measurement is performed at the end point of the reaction, the reaction efficiency itself of PCR has not been considered to greatly affect the measurement result. However, in practice, even when the measurement is performed at the end point, fluorescence intensity variation due to inhomogeneity of PCR reaction efficiency of each micropartition is large, and measurement reproducibility and measurement accuracy of digital PCR are deteriorated.
Therefore, in order to improve measurement reproducibility and measurement accuracy of digital PCR, the present inventors have developed a technology capable of discriminating a target gene or target DNA in a micropartition by measuring a melting temperature (Tm) of a PCR amplicon even when the PCR reaction efficiency of each micropartition is non-uniform (PTL 5). Specifically, for example, by measuring melting temperature (Tm) at which the target gene or target DNA amplified in the micropartition and the fluorescent-labeled probe dissociate after PCR, a genotype of the target gene or target DNA can be identified by a difference in melting temperature even if the reaction efficiency of PCR is non-uniform.
In the detection of target gene or target DNA, the presence of pseudogene may be problematic. In the process of evolution of organisms, new genes are acquired, while pseudogenes that have lost their functions have also been generated. A pseudogene is one in which a gene has made copies in the process of evolution, one has an original function, the other has changed, and the changed gene has lost its function without acquiring a new function. For this reason, sequences of KRAS gene and KRASP1 gene which is its pseudogene have extremely high homology.
Therefore, when there is a pseudogene in a target gene or target DNA, the target gene or target DNA and the pseudogene cannot be discriminated from each other, and the pseudogene is erroneously counted as the target gene or target DNA, and the copy number of target genes or target DNAs may be larger than the true value.
In the conventional quantitative PCR, the target gene or target DNA and the pseudogene exist in the same one partition. Thus, if a primer is designed by selecting a portion in which the sequence of the target gene or target DNA and the pseudogene does not match even only several bases, amplification of the target gene or target DNA and that of the pseudogene compete, amplification of the pseudogene is suppressed, and the target gene or target DNA can be preferentially amplified.
However, digital PCR has had a problem that it is difficult to distinguish the pseudogenes.
In digital PCR, unlike quantitative PCR, a reaction solution to which a specimen is added is divided into minute partitions so that one molecule of a target gene or target DNA is contained or not contained in one partition. For this reason, only one of the target gene or target DNA and the pseudogene is present in one partition.
Therefore, even when there are several bases in the pseudogene in a portion that does not match a primer region designed for the target gene or target DNA, there is no competition with the target gene or target DNA in a micropartition containing only the pseudogene, and thus there has been a problem that the pseudogene is amplified and the pseudogene becomes a false positive of the target gene or target DNA.
Distinguishing a target gene or target DNA from a pseudogene is important in reducing false positives and false negatives and improving measurement reproducibility and measurement accuracy.
Therefore, an object of the present invention is to provide a new DNA detection method and a DNA detection system for accurately distinguishing a micropartition in which a target gene or target DNA is placed and a micropartition in which a pseudogene is placed by a measuring device and accurately counting the target gene or target DNA in digital PCR using melting curve analysis.
The present inventors have found that in digital PCR using melting curve analysis, if probes are designed so that the melting temperatures of a target gene or target DNA and a pseudogene are different from each other, the target gene or target DNA and the pseudogene can be discriminated as different genes depending on the melting temperature, and further, it can be determined that they are the target gene or target DNA and the pseudogene from the correspondence relation between the count numbers of two genes, thereby completing the present invention.
An example of a DNA detection method according to the present invention includes the steps of: placing a DNA solution in each of a plurality of partitions, wherein the DNA solution may contain a plurality of types of DNAs including a first gene and a pseudogene of the first gene, and the DNA solution contains a fluorescent-labeled probe or a DNA intercalator; performing PCR in each of the partitions; changing a temperature of each of the partitions during the PCR or after the PCR, and measuring a fluorescence intensity changing with the temperature change for each of the partitions; calculating a melting temperature of a double strand DNA placed in the partition, for each of the partitions, based on a change in the fluorescence intensity accompanying the temperature change; discriminating the type of DNA for each of the partitions based on the melting temperature, and counting the number of partitions for each type of the DNA; outputting the number of partitions counted for each type of the DNA; and discriminating the first gene and the pseudogene based on the melting temperature and the number of the counted partitions.
An example of a DNA detection system according to the present invention includes: an imaging device that captures an image of a device capable of arranging a DNA solution in each of a plurality of partitions, wherein the DNA solution may contain a plurality of types of DNAs including a first gene and a pseudogene of the first gene, and the DNA solution contains a fluorescent-labeled probe or a DNA intercalator; a temperature adjustment unit that changes a temperature of each of the partitions in order to perform PCR in each of the partitions; a database that stores information indicating a reference melting temperature for each of a first gene and a pseudogene of the first gene; an imaging control unit that causes the imaging device to capture an image in order to acquire a fluorescence intensity changing with a temperature change for each of the partitions; a melting temperature memory that stores information indicating a melting temperature of a double strand DNA placed in the partition, for each of the partitions, wherein the melting temperature is obtained based on a change in the fluorescence intensity accompanying a temperature change in an image captured by the imaging device; and an analysis unit that counts the number of partitions in which the first gene is placed and the number of partitions in which the pseudogene is placed using the database and the melting temperature memory, wherein the analysis unit outputs the number of partitions counted for each type of the DNA and discriminates the first gene and the pseudogene based on the melting temperature and the number of counted partitions.
According to the present invention, there are provided a new DNA detection method and a new DNA detection system that more accurately distinguish a micropartition in which a target gene or target DNA is placed and a micropartition in which a pseudogene is placed by a measuring device and more accurately count the target gene or target DNA in digital PCR using melting curve analysis.
(
Objects, features, advantages, and ideas thereof of the present invention will be apparent to those skilled in the art from the description of the present specification. From the description of the present specification, those skilled in the art can easily reproduce the present invention. The embodiments, specific examples and the like of the invention described below illustrate preferred embodiments of the present invention and are shown for purposes of illustration or description and do not limit the present invention. It will be apparent to those skilled in the art that various alterations and modifications can be made based on the description herein without departing from the spirit and scope of the present invention disclosed herein.
The relationship between the fluorescence intensity and the melting temperature is plotted for a micropartition 101 containing wild-type alleles of the target gene or target DNA, a micropartition 102 containing mutant alleles of the target gene or target DNA, and a micropartition 103 containing pseudogenes of the target gene or target DNA.
In addition,
In digital PCR, a plurality of types of mutations may be detected by one set of measurements using a fluorescent-labeled probe having different colors for respective mutations (genotype) of DNA. The example of
Here, it is assumed that the fluorescent-labeled probe is complementary to the sequence positioned between a primer pair used in PCR, and is configured such that the probe is degraded and the fluorescent label emits fluorescence when the primer extends. Specifically, a TaqMan (registered trademark) probe can be given as an example.
When the DNA is amplified during PCR, in the micropartition 201 containing wild-type alleles of the target gene or target DNA, the yellow fluorescent-labeled probe corresponding to the wild-type allele of the target gene or target DNA is degraded, and yellow fluorescence is emitted. In addition, in the micropartition 202 containing mutant alleles of the target gene or target DNA, the green fluorescent-labeled probe corresponding to a mutant A allele of the target gene or target DNA is degraded, and green fluorescence is emitted. Neither green nor yellow fluorescence is detected in empty droplets containing no target gene or target DNA (not shown).
However, in practice, as shown in
In digital PCR using melting curve analysis, it is possible to discriminate between genotypes by utilizing the fact that the melting temperatures of a fluorescent-labeled probe and DNA vary depending on the genotype. The example of
Here, as the fluorescent-labeled probe, for example, a well-known molecular beacon can be used. Hereinafter, a DNA detection method will be described in detail using a molecular beacon as an example. A molecular beacon is configured as an oligonucleotide, and has a sequence complementary to a sequence between a primer pair used in PCR for amplifying a target gene or target DNA. In addition, the molecular beacon has mutually complementary sequences at both ends, and a fluorescent dye is provided at one end and a quenching dye (quencher) is provided at the other end.
When a molecular beacon is hybridized with a target gene or target DNA, it emits fluorescence with the fluorescent dye and the quenching dye at both ends being separated from each other. However, when the molecular beacon is dissociated from the target gene or target DNA with an increase in temperature, complementary sequences at both ends are hybridized with each other to form a stem-loop structure, and the fluorescent dye and the quenching dye approach each other to quench the fluorescent dye.
In the micropartition 101 containing wild-type alleles of the target gene or target DNA, a fluorescent-labeled probe corresponding to the wild-type allele of the target gene or target DNA hybridizes to DNA amplified by PCR to emit fluorescence, and a melting temperature corresponding to the fluorescent-labeled probe of the wild-type allele is observed.
In addition, in the micropartition 102 containing mutant alleles of the target gene or target DNA, a fluorescent-labeled probe corresponding to the mutant allele of the target gene or target DNA hybridizes to DNA amplified by PCR to emit fluorescence, and a melting temperature corresponding to the fluorescent-labeled probe of the mutant allele is observed.
Furthermore, in the micropartition 103 containing pseudogenes of the target gene or target DNA, a fluorescent-labeled probe corresponding to the wild-type allele of the target gene or target DNA hybridizes to DNA amplified by PCR in a form containing a mismatch base to emit fluorescence, and a melting temperature corresponding to this mismatch hybridization is observed.
Thus, the presence or absence of a target gene or target DNA having a wild-type allele, the presence or absence of a target gene or target DNA having a mutant allele, and the presence or absence of a target gene or target DNA having a pseudogene can be determined based on the fluorescence intensity, the type (for example, color) of fluorescence, and the melting temperature.
Since the melting temperature of DNA is not affected by the reaction efficiency of PCR, in-plane measurement variation at the time of fluorescence measurement, and the like, it is possible to discriminate the genotype of DNA in a micropartition with high accuracy. For example, the sequence of the fluorescent-labeled probe is determined so that the melting temperature (Tm) of each fluorescent-labeled probe with respect to the target gene or target DNA is different, the fluorescence intensity change accompanying the temperature change is measured with respect to the DNA in the micropartition, the melting curve analysis is performed, and the melting temperature is compared, whereby the genotype of the DNA in the micropartition can be discriminated.
Furthermore, the relationship (for example, ratio) between the copy number of target genes or target DNAs and the copy number of their pseudogenes is determined by the position of each gene on the chromosome, and for example, when both exist on autosomes, their copy numbers are equal to each other. Therefore, the genotype of DNA in each micropartition is counted, and whether or not the relationship between the sum of the wild-type copy number and the mutant copy number of target genes or target DNAs and the copy number of pseudogenes conforms to an expected relationship (for example, 1: 1) is confirmed, whereby more accurate gene detection becomes possible.
The DNA detection system according to Embodiment 1 includes a DNA detection device for detecting a target gene or target DNA in a DNA solution, and executes the DNA detection method described in the present specification. In the present embodiment, the single DNA detection device constitutes the DNA detection system, but a plurality of devices can be designed to cooperate to constitute the DNA detection system.
A DNA detection device includes a temperature adjustment unit for heating a DNA solution, a fluorescence measurement unit for measuring an intensity of fluorescence emitted from the DNA solution, a computer for calculating a melting temperature of a double strand DNA based on a melting curve representing a change in the intensity of the fluorescence accompanying a temperature change of the DNA solution, and a monitor for displaying information transmitted from the computer.
The DNA solution may be in any carrier, for example, may be provided as droplets in oil, or placed in a well such as a plate. As an example of the DNA detection device, a DNA detection device having a fluorescence measurement unit is shown with reference to
In the example of the fluorescence measurement unit shown in
The fluorescence measurement unit includes the light source 304, the fluorescence filter 305, and the photomultiplemeter 306. The fluorescence measurement unit may be separately provided for each color of the fluorescent dye, or may be configured to excite two types of fluorescent dyes with excitation light of one light source and simultaneously detect each fluorescence by two fluorescence filters as shown in
In addition, the droplets may be arranged on a plane as shown in
This will be described more specifically. For example, a plurality of droplets 311 are arranged in an array in a droplet detection cartridge 310 and set on a temperature control stage 312 which is a temperature adjustment unit. The temperature control stage 312 changes the temperature of each partition in order to perform PCR in each partition. The temperature of the droplet detection cartridge is changed by the temperature control stage 312, and the change in the fluorescence intensity of the droplets accompanying the temperature change is measured. The fluorescence intensity changes differently between the droplet 301 containing the target gene or target DNA and the droplet 302 not containing the target gene or target DNA.
The measurement procedure is as follows, for example. First, each droplet 311 is irradiated with excitation light from the light source 304 through a lens 308, the fluorescence filter 305, and a dichroic mirror 309. The fluorescent substance contained in each droplet 311 is excited by the excitation light, and emitted fluorescence is detected by a CCD camera 307 through the dichroic mirror 309, the fluorescence filter 305, and the lens 308. The CCD camera 307 is an example of an imaging device.
In
Further, as shown in
This will be described more specifically. For example, a reaction solution containing a specimen is added to wells provided in a cartridge 313 for well type detection. Thereafter, PCR is performed in the wells, and the wells are set on the temperature control stage 312 as a temperature adjustment unit. The temperature of the cartridge 313 is changed by the temperature control stage 312, and the change in the fluorescence intensity of the wells accompanying the temperature change is measured. The fluorescence intensity changes differently between a well 314 containing the target gene or target DNA and a well 315 not containing the target gene or target DNA.
The measurement procedure is as follows, for example. First, each well is irradiated with excitation light from the light source 304 through the lens 308, the fluorescence filter 305, and the dichroic mirror 309. The fluorescent substance contained in the reaction solution in the wells is excited by the excitation light, and emitted fluorescence is detected by the CCD camera 307 through the dichroic mirror 309, the fluorescence filter 305, and the lens 308. When the well is used as shown in
When the change in the fluorescence intensity of the well accompanying the temperature change is observed, an inclination adjustment unit (not shown) may be provided under the temperature control stage 312. The inclination adjustment unit removes air bubbles generated in the cartridge 313 by heating by the temperature control stage 312. This prevents that a fluorescence image cannot be acquired due to air bubbles when the fluorescence intensity of each well is measured while the temperature of a sample is lowered by the temperature control stage 312.
As shown in
In addition, the relationship among the type, melting temperature, and number of genes is prepared in advance in database 404. In particular, the database 404 stores information indicating a predetermined melting temperature to be standard (reference melting temperature) for each of a target gene or target DNA (first gene) and a pseudogene of the target gene or target DNA. With reference to the database 404, the genotype of the target gene or target DNA is discriminated based on the measured value of the melting temperature of the memory 405, and is counted for each genotype.
The count result is displayed on the monitor 406. The monitor 406 is an example of an output device, and display processing on the monitor 406 may be replaced with output processing to another output device (printing device, non-volatile storage device, or the like).
The DNA detection device according to Embodiment 1 may include a sample dividing unit. The sample dividing unit divides the DNA solution containing the target gene or target DNA into micropartitions. The micropartitions may be configured as wells arranged in an array in a cartridge, or may be configured as droplets dispersed in oil. By configuring the partitions in this way, limiting dilution can be performed appropriately.
In addition, the DNA detection device according to Embodiment 1 may include an amplification unit for amplifying DNA with respect to a micropartition.
In the example of
The information indicating a reference melting temperature is defined in this example as a value indicating a single temperature, but may also be defined as information indicating a range of temperatures.
Further, in this example, in addition to the reference melting temperature, information indicating the color of the fluorescent dye is stored for each genotype of each gene.
Furthermore, in this example, for each gene, information indicating the relationship between the number of target genes or target DNAs (genotypes are not distinguished) and the number of their pseudogenes is stored. This relationship is expressed, for example, as a ratio. In the example of
Since the relationship between the copy numbers of target genes or target DNAs and their pseudogenes is determined by their positions on chromosomes, the copy number relationship may be defined for each positional relationship on the chromosome. Specific examples are shown below.
First, a case where the target gene or target DNA is on an autosome will be described. In this case, when the pseudogene is on an autosome, the number of pseudogenes is equal to the number of target genes or target DNAs (gene A in
Next, a case where the target gene or target DNA is on an X chromosome will be described. In this case, when the pseudogene is present on an autosome, the number of pseudogenes is equal to the number of target genes or target DNAs in a female specimen, whereas the number of pseudogenes is twice the number of target genes or target DNAs in a male specimen. When the pseudogene is on an X chromosome, the number of pseudogenes is equal to the number of target genes or target DNAs (gene A in
Furthermore, a case where the target gene or target DNA is on a Y chromosome will be described. In this case, the number of target genes or target DNAs is zero in a female specimen. When a male specimen has a pseudogene on an autosome, the number of pseudogenes is twice the number of target genes or target DNAs. When a male specimen has a pseudogene on an X chromosome, the number of pseudogenes is equal to the number of target genes or target DNAs. When a male specimen has a pseudogene on a Y chromosome, the number of pseudogenes is equal to that of target genes or target DNAs.
When a fluorescent-labeled probe 602 exists alone in isolation as shown in
Thereafter, when the specimen solution is heated, the DNA 601 and the fluorescent-labeled probe 602 are dissociated as shown in
Moreover, the measurement of the melting curve may be performed in parallel with the PCR, or may be performed by raising the temperature of the specimen solution independently of the PCR (for example, after completion of the PCR).
In the melting curve of
As described above, the melting temperature can be calculated as the inflection point of the fluorescence intensity. According to such a calculation method, the melting temperature can be accurately calculated.
The melting temperature of the fluorescent-labeled probe for detecting the target gene or target DNA can be controlled based on a known technique. For example, it can be controlled by changing the sequence or chain length of the probe. Alternatively, it can also be controlled by using artificial DNA such as peptide nucleic acid (PNA) or locked nucleic acid (LNA).
In the fluorescent-labeled probe 602 used here, the combination of the fluorescent dye 603 and the quencher 604 is not particularly limited as long as it is a combination generally used for real-time PCR. Examples of the fluorescent dye 603 include FAM, VIC, ROX, Cy3, Cy5 and the like, and examples of the quencher 604 include TAMRA, BHQ1, BHQ2, BHQ3 and the like.
As the sequence of the fluorescent-labeled probe 602, sequences specific to wild-type of the target gene or target DNA, a mutant of the target gene or target DNA, and a pseudogene of the target gene or target DNA are each prepared, and these may be individually detected. In this case, as shown in
Alternatively, specific sequences are prepared for the wild-type of the target gene or target DNA and the mutant of the target gene or target DNA, and a fluorescent-labeled probe having a sequence specific to the wild-type of the target gene or target DNA may be mishybridized with respect to the pseudogene to detect the target gene or target DNA. In this case, as shown in
In a modification of Embodiment 1, a DNA intercalator can be used instead of the fluorescent-labeled probe. As a specific method, first, a DNA intercalator is added to a PCR reaction solution to prepare a specimen solution, and PCR such as PCR is performed. At a temperature of about room temperature, the DNA intercalator binds to a double-stranded DNA amplified in the specimen solution and emits strong fluorescence.
Thereafter, as the temperature of the specimen solution increases, the double-stranded DNA in the specimen solution is dissociated to become single-stranded DNA, and the DNA intercalator does not bind, so that the fluorescence intensity decreases. Incidentally, the measurement of the fluorescence intensity change with respect to the temperature change may be performed by raising the temperature of the specimen solution independently of the PCR (for example, after completion of the PCR).
The melting temperature of the target gene or target DNA can be controlled depending on the sequence and chain length of the sequence of the PCR amplicon by changing the design of the primer.
As the DNA intercalator, an intercalator that increases the fluorescence intensity by binding to double-stranded DNA and can be used for detecting double-stranded DNA is used. Specifically, SYBR (registered trademark) Green I, SYBR Gold, PicoGreen (registered trademark), SYTO (registered trademark) Blue, SYTO Green, SYTO Orange, SYTO Red, POPO (registered trademark)-1, BOBO (registered trademark)-1, YOYO (registered trademark)-1, TOTO (registered trademark)-1, JOJO (registered trademark)-1, POPO-3, LOLO (registered trademark)-1, BOBO-3, YOYO-3, TOTO-3, PO-Pro (registered trademark)-1, YO-Pro (registered trademark)-1, TO-Pro (registered trademark)-1, JO-Pro (registered trademark)-1, PO-Pro-3, YO-Pro-3, TO-Pro-3, TO-Pro-5, ethidium bromide and the like can be applied. When the DNA intercalator is heat resistant, the DNA intercalator can be added to the well or droplet before the PCR reaction is performed.
A method for analyzing the melting temperature of the target gene or target DNA and the pseudogene using the principle of
A PCR reaction solution containing a specimen, a fluorescent-labeled probe and enzymes is divided into micropartitions. After the PCR processing, the fluorescence intensity of each partition is calculated based on the fluorescence image acquired while changing the temperature, and stored in the memory 405 as shown in
In the example of
Next, a melting curve of each partition is created based on the fluorescence intensity change with respect to the temperature change of each partition. Next, the value of the melting temperature of each partition is calculated based on the melting curve of each partition, and stored in the memory 405 as shown in
Next, determination is made on the relationship between the number of target genes or target DNAs (the total number of wild-type and mutants) and the number of pseudogenes with reference to the database 404. The determination is made, for example, based on whether or not the measured ratio of the number of pseudogenes to the number of target genes or target DNAs conforms to the ratio recorded in the database 404.
As a specific example, in the case of detecting gene A shown in
In the case of gene A in
If the measured ratio conforms to the ratio recorded in the database 404, information indicating conformity is displayed on the monitor 406. If there is non-conformity, information indicating non-conformity (for example, information indicating that a measurement error has occurred) is displayed on the monitor 406. These pieces of information can be reflected in accuracy control of digital PCR. In addition, when a measurement error occurs at a frequency equal to or higher than a preset reference, an alert may be displayed on the monitor 406. The alert includes, for example, information indicating that a user needs to adjust a digital PCR system.
An example of a method for measuring melting temperature will be described with reference to a flowchart of
First, a database 404 regarding a gene to be measured by digital PCR is prepared (S1001). Next, a specimen solution derived from a biological sample containing DNA (DNA solution) is prepared. The specimen solution may contain a plurality of types of DNAs including a target gene or target DNA (first gene) and its pseudogene. This specimen solution is added to a PCR reaction solution. The PCR reaction solution contains a DNA polymerase, a primer, a DNA intercalator or a molecular beacon, deoxyribonucleotides, and a buffer solution. As a result, the specimen solution contains a fluorescent-labeled probe or the DNA intercalator.
The PCR reaction solution is divided into wells arranged in an array in a cartridge 313 (S1002). This step is a step of placing the specimen solution in each of the plurality of partitions. Here, in the present embodiment, digital PCR processing is performed. That is, the specimen solution placed in each partition is subjected to limiting dilution, which enables execution of digital PCR.
Next, the cartridge 313 is set in a thermal cycler, and PCR is performed by temperature control of the thermal cycler (S1003). This is a step of performing PCR in each partition. DNA is amplified by repeating a cycle including a denaturation step, an extension step, and an annealing step.
If a DNA intercalator is used, it intercalates to the amplified DNA, and if a molecular beacon is used, it hybridizes to the amplified DNA. This increases the fluorescence intensity. The reaction conditions including the temperature, time, number of cycles and the like of each step can be easily set by those skilled in the art. After PCR, when the temperature is lowered to room temperature, the DNA forms a double strand.
After PCR, a fluorescence image is acquired (S1004). A detailed procedure example is as follows. The cartridge 313 is placed on a temperature control stage 312 of the DNA detection device. While the temperature of the cartridge 313 is changed by the temperature control stage 312, a fluorescence measurement unit 401 measures the fluorescence intensity from the DNA intercalator or molecular beacon of each well. As a result, a fluorescence image is acquired.
Step of S1004 is a step of changing the temperature of each partition and measuring the fluorescence intensity changing with the temperature change for each partition. The step of S1004 may be performed during the PCR or may be performed after the PCR.
In the step of S1004, a computer 402 or another component may function as an imaging control unit. The imaging control unit causes an imaging device (for example, photomultiplemeter 306) to capture an image in order to acquire a fluorescence intensity changing with a temperature change for each partition.
Next, the obtained fluorescence image is sent to the computer 402, and the fluorescence intensity of each micropartition is calculated by an analysis unit 403 and stored in a memory 405 (S1005).
The analysis unit 403 creates a melting curve based on the fluorescence intensity data (S1006), calculates a melting temperature using the melting curve, and stores the melting temperature in the memory 405 (S1007). This step includes a step of calculating, for each partition, the melting temperature of the double strand DNA placed in the partition, based on the fluorescence intensity change accompanying the temperature change. In this way, the measured melting temperature is obtained.
In addition, the analysis unit 403 refers to the data on the reference melting temperature in the database 404, and counts the number of each of wild-type, mutants, and pseudogenes of the target gene or target DNA on the basis of the measured melting temperature of the memory 405 (S1008). Step of S1008 includes a step of discriminating the type of DNA for each partition based on the reference melting temperature and the measured melting temperature, and counting the number of partitions for each type of DNA.
As described above, in S1008, the analysis unit 403 counts the number of partitions in which the target gene or target DNA (first gene) is placed and the number of partitions in which the pseudogene is placed using the database 404 and the memory 405. In addition, in S1008, the analysis unit 403 may determine whether or not the target gene or target DNA and the pseudogene of the target gene or target DNA are contained in the specimen solution.
The distinction between wild-type, mutant, and pseudogene can be made based on the reference melting temperature and the measured melting temperature. For example, in the case of gene A in
This determination may be made based on a range. For example, when the measured melting temperature according to a well is within a predetermined range (for example, within the reference melting temperature ±1° C.) including the reference melting temperature recorded in the database 404 for a genotype, it can be determined that a gene of the genotype is placed in the well. When using range with width in this manner, a robust determination can be made appropriately considering allowable range.
Next, the analysis unit 403 determines the relationship between the number of target genes or target DNAs (the total number of wild-type and mutants) and the number of pseudogenes. That is, the target gene or target DNA and the pseudogene are discriminated from the melting temperature and the number of counted partitions. For example, it is determined whether the ratio is 1, ½, 2, 0, or none of these. The result is output (S1009). Here, as described above, this determination may be made based on a range. For example, in step of S1009, the analysis unit 403 determines whether the ratio of the number of partitions in which the pseudogene is placed to the number of partitions in which the target gene or target DNA (first gene) is placed is a value within a range corresponding to 1, a value within a range corresponding to ½, a value within a range corresponding to 2, a value within a range corresponding to 0, or a value not within any range. In this way, by automatically determining the correspondence relation, a user of the device can more easily grasp the content of the specimen solution.
Finally, the monitor 406 outputs the number of target genes or target DNAs and the total number of genes in the cartridge to the monitor (S1010). For example, the numbers of partitions counted for respective types of DNA are output.
In S1008, in the determination of whether the DNA of each well is positive (that is, the gene is placed in the well) or negative (that is, the gene is not placed in the well), information on the fluorescence intensity may be used.
For example, a fluorescence intensity value itself can be used as the fluorescence intensity information. If the fluorescence intensity of a well is within a predetermined range, the well is determined to be positive; otherwise the well is determined to be negative.
Alternatively, as the information of the fluorescence intensity, a ratio or a difference of fluorescence intensities at different temperatures may be used. For example, the fluorescence intensity can be standardized by using a ratio or a difference between the fluorescence intensity at a temperature lower than the reference melting temperature and the fluorescence intensity at a temperature higher than the reference melting temperature. For example, if the ratio or difference is within a predetermined range for a well, the well is determined to be positive; otherwise the well is determined to be negative.
For example, by subtracting the fluorescence intensity at 85° C. from the fluorescence intensity at 50° C., the fluorescence influence of the fluorescent-labeled probe itself, that is, the background influence, can be removed.
The method for determining the range of fluorescence intensity, the range of reference melting temperature, and the range of the correspondence relation (for example, ratio) between the copy number of target genes or target DNAs and the copy number of pseudogenes can be arbitrarily selected. For example, a pilot experiment or the like may be performed in advance and an operator may statistically determine the ranges from the result, or the DNA detection system may automatically determine the ranges. In addition, for each digital PCR measurement, the measurement data of each well in the cartridge may be used to statistically determine the threshold of the fluorescence intensity and the predetermined range of the reference melting temperature.
The data for statistically discriminating DNA in the well may include any or all of the following items, or may include other items.
The specimen solution to be used is not particularly limited as long as it is a sample containing DNA to be detected, and examples thereof include biological samples (body fluids and tissues, cells, excretions and the like of animals and plants) and soil samples (including fungi, bacteria, and the like).
Examples of the body fluid include blood, saliva, cerebrospinal fluid, and the like. The blood contains cell free DNA (cfDNA), circular tumor DNA (ctDNA), and the like. Examples of the tissue include affected parts (for example, cancer tissues of breast, liver and the like) of a disease obtained by a surgical operation or a biopsy. The tissue may be an already fixed tissue, for example, a formalin-fixed paraffin-embedded tissue (FFPE). Examples of the cell include cells (those in an affected part or the vicinity thereof) collected by a biopsy method and circular tumor cells circulating in blood, and the like.
Pretreatment of these specimens is not particularly limited, and those collected from a living body, an environment or the like and then added to a suspension to be homogenized or dissolved in a solution may be used as they are, but it is preferable to use those obtained by extracting or purifying the nucleic acid contained therein.
It is desirable to add oil to the upper surface of a PCR reaction solution so that the PCR reaction solution divided into wells does not evaporate during measurement of PCR and melting curve analysis. The oil is preferably a chemically inert substance that is insoluble or poorly soluble in the PCR reaction liquid, and is preferably a substance that is stable to a temperature change at a high temperature such as PCR. A fluorine-based oil, a silicone-based oil, a hydrocarbon-based oil or the like can be used.
Examples of the fluorine-based oil include perfluorocarbon, hydrofluoroether, and the like. The longer the carbon chain of the fluorine-based oil is, the lower the volatility of the fluorine-based oil is, which is preferable. Examples of the silicone-based oil include polyphenylmethylsiloxane, trimethylsiloxysilicate, and the like. Examples of the hydrocarbon-based oil include mineral oil, liquid paraffin, hexadecane, and the like.
The oil may be used by adding a surfactant. Here, the type of surfactant is not particularly limited, but Tween 20, Tween 80, Span80, Triton X-100 and the like can be applied.
As shown in
As shown in
The result displayed on the monitor may be the number or percentage of the specimen solution DNA as shown in
The range related to the fluorescence intensity of the fluorescent-labeled probe used for counting the number of DNAs may be arbitrarily changed by the user. In addition, the user may arbitrarily change the range related to the reference melting temperature used when counting the number of DNAs. The DNA detection system may accept an operation for changing these and change the corresponding range. In this way, the user can view the graph or histogram of the measurement result, change the range of the fluorescence intensity and/or the reference melting temperature, and count the number of DNAs in the specimen solution within the new range again.
In addition to the number or percentage of target genes or target DNAs, the count number of pseudogenes may be displayed. Moreover, the DNA detection device may determine whether or not the correspondence relation between the count number of target genes or target DNAs and the count number of pseudogenes is appropriate, and display the result on the monitor 406. For example, it may be determined whether or not the ratio of the count number of pseudogenes to the count number of target genes or target DNAs conforms to the value (or range) stored in the database 404, and if it conforms, information indicating that these count numbers conform (for example, a message indicating that the measurement has been performed normally) may be displayed on the monitor 406, and if not, information indicating that these count numbers do not conform (for example, a message indicating that a measurement error has occurred) may be displayed on the monitor 406.
As described above, since the specimen solution is treated as a solution in a well or a droplet, it may be expressed as the number of wells or the number of droplets instead of the number of DNAs in the specimen solution.
Another embodiment of the present invention is a program for causing a DNA detection device to perform a DNA detection method. Here, the DNA detection device may be, for example, the DNA detection device according to Embodiment 1, and executes the method described in detail in the above section (1) as the DNA detection method using the device described in detail in the above section (2).
Further, still another embodiment of the present invention is a recording medium that stores the program.
In this example, melting temperature of DNA in a well is measured using a fluorescent-labeled probe, and a result of discriminating between BRAF gene and its pseudogene is shown.
It is known that the BRAF gene is present on chromosome 7, which is an autosome, and its pseudogene BRAFP1 is present on an X chromosome. The specimen used in this example is genomic DNA of HCT116, which is a human colon cancer-derived cell line, and since it is male genomic DNA, the copy number of pseudogenes of BRAF gene should be half the sum of the wild-type and mutant copy numbers.
First, for the BRAF gene, wild-type and V600E mutant genomic DNAs (final concentration 133 molecules/μL) are prepared. A forward primer (final concentration 0.25 μM), a reverse primer (final concentration 2.0 μM), a fluorescent-labeled probe corresponding to the wild-type (final concentration 0.5 μM), and 1× master mix (including DNA polymerase and dNTP), which were required for PCR, were added to prepare a PCR reaction solution. At this time, the primer pair was added so that the concentration of the primer pair was asymmetric so that the complementary DNA strand of the fluorescent-labeled probe was excessively amplified.
Sequences of primers and probes are as follows. All of the fluorescent-labeled probes have complementary sequences near both ends, and are designed so that they form a double strand in the molecule. In addition, CAL Fluor Red 610 as a fluorescent dye is bound to the 5′ end, and BHQ-2 as a quencher is bound to the 3′ end.
Fluorescent-labeled probe corresponding to BRAF gene wild-type: 5′-GGTCTAGCTACAGTGAAATC-3′ (SEQ ID NO: 3)
Thereafter, 15 μL of a PCR reaction solution was added so that one wild-type DNA of BRAF gene, one V600E mutant DNA, one pseudogene DNA, or none of them is contained in each well, and DNA was amplified by PCR.
In the PCR reaction, treatment was performed at 96° C. for 10 minutes, followed by 59 cycles of cycles (60° C. for 2 minutes, then 98° C. for 30 seconds), and finally treatment was performed at 60° C. for 2 minutes. After the reaction, a change in the fluorescence intensity of each well was observed while a chip provided with the well was cooled from 85° C. to 50° C. on a temperature control stage, and melting curves were measured and analyzed.
The results are shown in
Comparing the count numbers of respective populations in
As described above, the measurement accuracy can be guaranteed by discriminating and counting each of the target gene or target DNA and the pseudogene using the measured melting temperature for discrimination of the genotype in the digital PCR, and confirming that the target gene or target DNA and the pseudogene match with the correspondence relation of the copy number obtained in advance from the position on the chromosome.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/JP2020/001171 | 1/16/2020 | WO |
